238 related articles for article (PubMed ID: 2659296)
1. A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Rivera-Vazquez CR; Ramirez-Ronda CH; Rodriguez JR; Saavedra S
Chemotherapy; 1989; 35 Suppl 1():89-100. PubMed ID: 2659296
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli.
Rodríguez JR; Ramírez-Ronda CH; Nevárez M
Antimicrob Agents Chemother; 1985 Feb; 27(2):246-51. PubMed ID: 4039118
[TBL] [Abstract][Full Text] [Related]
3. Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.
Birolini D; Moraes MF; de Souza OS
Chemotherapy; 1989; 35 Suppl 1():49-57. PubMed ID: 2659290
[TBL] [Abstract][Full Text] [Related]
4. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intraabdominal infections.
Barboza E; del Castillo M; Yi A; Gotuzzo E
Surgery; 1994 Jul; 116(1):28-35. PubMed ID: 8023265
[TBL] [Abstract][Full Text] [Related]
5. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
[TBL] [Abstract][Full Text] [Related]
6. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli.
Nolen TM; Phillips HL; Hall HJ
Rev Infect Dis; 1985; 7 Suppl 4():S666-8. PubMed ID: 3909321
[TBL] [Abstract][Full Text] [Related]
7. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
Birolini D; Moraes MF; de Souza OS
Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
[TBL] [Abstract][Full Text] [Related]
8. Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.
Schentag JJ; Vari AJ; Winslade NE; Swanson DJ; Smith IL; Simons GW; Vigano A
Am J Med; 1985 Feb; 78(2A):34-41. PubMed ID: 3881947
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam plus clindamycin versus tobramycin plus clindamycin in the treatment of intraabdominal infections.
Williams RR; Hotchkin D
Rev Infect Dis; 1991; 13 Suppl 7():S629-33. PubMed ID: 2068472
[TBL] [Abstract][Full Text] [Related]
10. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
[TBL] [Abstract][Full Text] [Related]
11. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections.
Swabb EA; Cone CO; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S675-8. PubMed ID: 3909323
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
Torres A; de Celis R; Rabinad E; Marco F; Almela M; Deulofeu R; Rodriguez-Roisin R; Agusti Vidal A
Chemotherapy; 1989; 35 Suppl 1():15-24. PubMed ID: 2659289
[TBL] [Abstract][Full Text] [Related]
13. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
[TBL] [Abstract][Full Text] [Related]
15. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
Feld R; Valdivieso M; Bodey GP; Rodriguez V
J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
DeMaria A; Treadwell TL; Saunders CA; Porat R; McCabe WR
Antimicrob Agents Chemother; 1989 Aug; 33(8):1137-43. PubMed ID: 2679368
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
Tsuda S; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Horiike S; Taniwaki M; Misawa S; Inazawa J; Abe T
Jpn J Antibiot; 1989 Sep; 42(9):1926-37. PubMed ID: 2810755
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
Marco V; Gobernado M; Santos M; Rabinad E
Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
[TBL] [Abstract][Full Text] [Related]
19. Results of a randomized, multicenter trial of meropenem versus clindamycin/tobramycin for the treatment of intra-abdominal infections.
Wilson SE
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S197-206. PubMed ID: 9126694
[TBL] [Abstract][Full Text] [Related]
20. Presumptive antibiotics for penetrating abdominal wounds.
Moore FA; Moore EE; Ammons LA; McCroskey BL
Surg Gynecol Obstet; 1989 Aug; 169(2):99-103. PubMed ID: 2667180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
